SHANGHAI BAO PHARMACEUTICALS CO., LTD. - B - H SHARES
(HKEX: 2659)
Shanghai Bao Pharmaceutical Co. Ltd. engages in the research and development of pharmaceutical products. It focuses on the following therapeutic areas: subcutaneous delivery, antibody-mediated auto-immune diseases, assisted reproduction, and synthetic biology upgrading platform. The company was founded by Yan Jun Liu and Zheng Wang on December 16, 2019 and is headquartered in Shanghai, China.
68.350 -
-0.650
(-0.94%)
Range
66.700 - 70.000
(4.95%)
Open
69.000
Previous Close
69.000
Bid Price
68.350
Bid Volume
('000)
0.6
Ask Price
68.400
Ask Volume
('000)
0.3
Volume
('000)
831.2
Value
56,740,624
Remark
-
Delayed prices. Updated at 12 Dec 2025 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
